Effect of natural polyphenols (Pycnogenol) on oxidative stress markers in children suffering from Crohn's disease – a pilot study

References

• Yoshida EM. The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn's disease. Can J Gastroenterol 1999;13:65–73.
   PubMed Web of Science ®Google Scholar
• Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439–447.
   PubMed Web of Science ®Google Scholar
• Kappelman MD, Crandall WV, Colletti RB, Goudie A, Leibowitz IH, Duffy L, et al. A short pediatric Crohn's disease activity index for quality improvement and observational research. Inflamm Bowel Dis 2011;17:112–117.
   PubMed Web of Science ®Google Scholar
• Sies H (ed.). Oxidative Stress: Oxidants and Antioxidants. London; San Diego: Academic Press; 1991. 650 p.
   Google Scholar
• Ďuračková Z. Some current insights into oxidative stress. Physiol Res 2010;59:459–469.
   PubMed Web of Science ®Google Scholar
• Krzystek-Korpacka M, Neubauer K, Berdowska I, Boehm D, Zielinski B, Petryszyn P, et al. Enhanced formation of advanced oxidation protein products in IBD. Inflamm Bowel Dis 2008; 14:794–802.
   PubMed Web of Science ®Google Scholar
• Maor I, Rainis T, Lanir A, Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci 2008;53:2208–2214.
   PubMed Web of Science ®Google Scholar
• Wendland BE, Aghdassi E, Tam C, Carrrier J, Steinhart AH, Wolman SL, et al. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 2001;74: 259–264.
   PubMedGoogle Scholar
• Phylactos AC, Fasoula IN, Arnaud-Battandier F, Walker-Smith JA, Fell JM. Effect of enteral nutrition on antioxidant enzyme systems and inflammation in paediatric Crohn's disease. Acta Paediatr 2001;90:883–888.
   PubMedGoogle Scholar
• Krzystek-Korpacka M, Neubauer K, Berdowska I, Zielinski B, Paradowski L, Gamian A. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment. Inflamm Bowel Dis 2010;16: 1467–1475.
   PubMedGoogle Scholar
• Beltrán B, Nos P, Dasí F, Iborra M, Bastida G, Martínez M, et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease. Inflamm Bowel Dis 2010;16:76–86.
   PubMed Web of Science ®Google Scholar
• Iborra M, Moret I, Rausell F, Bastida G, Aguas M, Cerrillo E, et al. Role of oxidative stress and antioxidant enzymes in Crohn's disease. Biochem Soc Trans 2011;39:1102–1106.
   PubMed Web of Science ®Google Scholar
• Kruidenier L, Kuiper I, Lamers CBHW, Verspaget HW. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003;201:28–36.
   PubMed Web of Science ®Google Scholar
• Romier B, Schneider YJ, Larondelle Y, During A. Dietary polyphenols can modulate the intestinal inflammatory response. Nutr Rev 2009;67:363–378.
   PubMed Web of Science ®Google Scholar
• Rohdewald PJ. Pycnogenol, French maritime pine bark extract. In: Coates P, Blackman MR, Cragg G, Levine M, Moss J, White J (eds.). Encyclopedia of Dietary Supplements. New York: Marcel Dekker; 2005. pp. 545–553.
   Google Scholar
• Grimm T, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Ďuračková Z, Högger P. Inhibition of NF-κB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (London) 2006;3:1–6. Available at: http://www.journal-inflammation.com/content/3/1/1 via the INTERNET. Accessed 2006 Jan 27.
   Google Scholar
• Schäfer A, Chovanová Z, Muchová J, Sumegová K, Liptáková A, Ďuračková Z, Högger P. Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol). Biomed Pharmacother 2006;60:5–9.
   PubMed Web of Science ®Google Scholar
• Golański J, Muchova J, Golański R, Durackova Z, Markuszewski L, Watała C. Does Pycnogenol intensify the efficacy of acetylsalicylic acid in the inhibition of platelet function? In vitro experience. Postepy Hig Med Dosw (online)2006;60:316–321. Available at: http://www.phmd.pl/pub/phmd/vol_60/9431.pdf via the INTERNET. Accessed 2006 June 23.
   Google Scholar
• Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 2002;40: 158–168.
   PubMed Web of Science ®Google Scholar
• MacKay D. Nutrients and botanicals for erectile dysfunction: examining the evidence. Altern Med Rev 2004;9:4–16.
   PubMedGoogle Scholar
• Koch R. Comparative study of Venostasin® and Pycnogenol® in chronic venous insufficiency. Phytother Res 2002; 16:S1–S5.
   PubMed Web of Science ®Google Scholar
• Križková L, Ďuračková Z, Krajčovič J. Natural polyphenols possess antioxidative and antimutagenic properties. 8. mezioborová česko - slovenská toxikologická konference 2003 Sept 3–5 Praha. Praha: [s.n.], 2003; 128 p.
   Google Scholar
• Belcaro G, Luzzi R, Cesinaro Di Rocco P, Cesarone MR, Dugall M, Feragalli B, et al. Pycnogenol® improvements in asthma management. Panminerva Med 2011;53:57–64.
   PubMedGoogle Scholar
• Frontela-Seta C, López-Nicolás R, González-Bermúdez CA, Peso-Echarri P, Ros-Berruezo G, Martínez-Graciá C, et al. Evaluation of antioxidant activity and antiproliferative effect of fruit juices enriched with Pycnogenol® in colon carcinoma cells. The effect of in vitro gastrointestinal digestion. Phytother Res 2011;25:1870–1875.
   PubMedGoogle Scholar
• Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, et al.; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of the pediatric Crohn´s disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005;41:416–421.
   PubMed Web of Science ®Google Scholar
• Bergmeyer HU (ed.). Methods of enzymatic analysis. Volume 3. Enzymes 1: Oxidoreductases, transferases. 3rd ed. Weinheim; Deerfield Beach/Florida; Basel: Verlag Chemie; 1983. 605 p.
   Google Scholar
• Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 1999;26:1231–1237.
   PubMed Web of Science ®Google Scholar
• El-Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jürgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627–630.
   PubMed Web of Science ®Google Scholar
• Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?Dig Dis Sci 2007;52:2015–2021.
   PubMed Web of Science ®Google Scholar
• Koutroubakis IE, Malliaraki N, Dimoulios PD, Karmiris K, Castanas E, Kouroumalis EA. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 2004;49:1433–1437.
   PubMed Web of Science ®Google Scholar
• Tüzün A, Erdil A, Inal V, Aydin A, Bağci S, Yeşilova Z, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002;35:569–572.
   PubMed Web of Science ®Google Scholar
• Paduchová Z, Ďuračková Z. Fecal calprotectin as a promising marker of inflammatory diseases. Bratisl Lek Listy 2009; 110:598–602.
   PubMedGoogle Scholar
• Wagner M, Peterson CGB, Ridefelt P, Sangfelt P, Carlson M. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008;14:5584–5589.
   PubMed Web of Science ®Google Scholar
• Henderson P, Casey A, Lawrence SJ, Kennedy NA, Kingstone K, Rogers P, et al. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2012;107:941–949.
   PubMed Web of Science ®Google Scholar
• Burri E, Beglinger C. Faecal calprotectin – a useful tool in the management of inflammatory bowel disease. Swiss Med Wkly 2012;142:w13557.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Hasegawa N. Therapeutic efficacy of Pycnogenol in experimental inflammatory bowel disease. Phytother Res 2004;18:1027–1028.
   PubMed Web of Science ®Google Scholar
• Rosillo MA, Sanchez-Hidalgo M, Cárdeno A, Alarcón de la Lastra C. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Biochem Pharmacol 2011;82:737–745.
   PubMed Web of Science ®Google Scholar
• Ďuračková Z, Trebatický B, Novotný V, Žitňanová I, Breza J. Lipid metabolism and erectile function improvement by Pycnogenol®, extract from the bark of Pinus pinaster in patients suffering from erectile dysfunction – a pilot study. Nutr Res 2003;23:1189–1198.
   Web of Science ®Google Scholar
• Chovanová Z, Muchová J, Sivoňová M, Dvořáková M, Žitňanová I, Waczulíková I, et al. Effect of polyphenolic extract, Pycnogenol®, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radic Res 2006;40:1003–1010.
   PubMed Web of Science ®Google Scholar
• Dvořáková M, Sivoňová M, Trebatická J, Škodáček I, Waczulíková I, Muchová J, Ďuračková Z. The effect of polyphenolic extract from pine bark, Pycnogenol®, on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep 2006;11: 163–172.
   PubMed Web of Science ®Google Scholar
• Cisár P, Jány R, Waczulíková I, Sumegová K, Muchová J, Vojtaššák J, et al. Effect of pine bark extract (Pycnogenol®) on symptoms of knee osteoarthritis. Phytother Res 2008;22:1087–1092.
   PubMed Web of Science ®Google Scholar
• Dvořáková M, Paduchová Z, Muchová J, Ďuračková Z, Collins AR. How does Pycnogenol® influence oxidative damage to DNA and its repair ability in elderly people?Prague Med Rep 2010;111:263–271.
   PubMedGoogle Scholar
• Errichi BM, Belcaro G, Hosoi M, Cesarone MR, Dugall M, Feragalli B, et al. Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study. Panminerva Med 2011;53:21–27.
   PubMedGoogle Scholar
• Peng YJ, Lee CH, Wang CC, Salter DM, Lee HS. Pycnogenol attenuates the inflammatory and nitrosative stress on joint inflammation induced by urate crystals. Free Radic Biol Med 2012;52:765–774.
   PubMed Web of Science ®Google Scholar
• Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ, et al. Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J 2012;33:1589–1597.
   PubMed Web of Science ®Google Scholar
• Viktorinova A, Trebaticka J, Paduchova Z, Ursinyova M, Uhnakova I, Masanova V, Durackova Z. Natural polyphenols modify trace element status and improve clinical symptoms of attention-deficit hyperactivity disorder. Biomed Pharmacother 2009. Available: http://www.sciencedirect.com/science?_ob = ArticleURL & _udi = B6VKN-4XGXKSV-2&_user = 5674000&_coverDate = 10%2F20%2F2009&_rdoc = 1&_fmt = high&_orig = search&_origin = search&_sort = d&_docanchor = &view = c&_acct = C000053045&_version = 1&_urlVersion = 0&_userid = 5674000&md5 = 0984b1b08367c2693936ebc45e5ecd33&searchtype = a via the INTERNET. Accessed 2009 Oct 20.
   PubMedGoogle Scholar
• Sivoňová M, Žitňanová I, Horáková Ľ, Štrosová M, Muchová J, Balgavý P, et al. The combined effect of Pycnogenol® with ascorbic acid and trolox on the oxidation of lipids and proteins. Gen Physiol Biophys 2006;25: 379–396.
   PubMed Web of Science ®Google Scholar
• Koláček M, Muchová J, Vranková S, Jendeková L, Pecháňová O, Uličná O, et al. Effect of natural polyphenols, Pycnogenol® on superoxide dismutase and nitric oxide synthase in diabetic rats. Prague Med Rep 2010;111: 279–288.
   PubMedGoogle Scholar
• Maritim A, Dene BA, Sanders RA, Watkins JB III. Effects of Pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2003;17: 193–199.
   PubMed Web of Science ®Google Scholar
• Parveen K, Khan MR, Mujeeb M, Siddiqui WA. Protective effects of Pycnogenol® on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 2010;186:219–227.
   PubMed Web of Science ®Google Scholar
• Yang YS, Ahn TH, Lee JC, Moon CJ, Kim SH, Jun W, et al. Protective effects of Pycnogenol® on carbon tetrachloride- induced hepatotoxicity in Sprague-Dawley rats. Food Chem Toxicol 2008;46:380–387.
   PubMed Web of Science ®Google Scholar
• Rieth AG, Baader SL, Lode HN, Bruchelt G, Niethammer D. Ferritin enhaces production of DNA strand breaks by 6-hyroxydopamine, scorbic acid and H2O2 in CCC PM2 bacteriophage DNA. BioMetals 1992;5:223–227.
   Google Scholar
• Halliwell B, Gutteridge J. Free radicals in biology and medicine. 4th ed. Oxford, New York: Oxford University Press; 2010. 851 p.
   Google Scholar
• Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr 2007;85:1185–1196.
   PubMed Web of Science ®Google Scholar
• Schmidt WU, Sattler J, Hesterberg R, Röher HD, Zoedler T, Sitter H, Lorenz W. Human intestinal diamine oxidase (DAO) activity in Crohn's disease: a new marker for disease assessment?Agents Actions 1990;30:267–270.
   PubMedGoogle Scholar
• Thompson JS, Burnett DA, Vaughan WP. Factors affectin plasma postheparin diamine oxidase activity. Dig Dis Sci 1991;36:1582–1588.
   PubMed Web of Science ®Google Scholar
• Honzawa Y, Nakase H, Matsuura M, Chiba T. Clinical significance of serum diamine oxidase activity in inflammatory bowel disease: Importance of evaluation of small intestinal permeability. Inflamm Bowel Dis 2011;17:E23–E25.
   PubMedGoogle Scholar
• Choi YH, Yan GH. Pycnogenol® inhibits immunoglobulin E-mediated allergic response in mast cells. Phytother Res 2009;23:1691–1695.
   PubMedGoogle Scholar
• Sharma SC, Sharma S, Gulati OP. Pycnogenol® inhibits the release of histamine from mast cells. Phytother Res 2003; 17:66–69.
   PubMed Web of Science ®Google Scholar